BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Rhinitis News and Headlines
Rhinitis news updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Rhinitis news alerts.
Site Map > Biotechnology News > Health News > Rhinitis
.

TopAbstracts in Rhinitis 06/30/2008
Doctors Guide:  similar ...
New treatment available in Canada for children with seasonal allergies and for adolescents and adults sufferin
Calibre Macro World:  similar ...
Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in All
Pharma Live:  similar ...
Duration of allergic rhinitis linked with worsening of nasal airflow
Clinical Lab Products:  similar ...
Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in All
DiGiTAL50:  similar ...
Duration of allergic rhinitis linked with worsening of nasal airflow
Reuters Health:  similar ...
Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in All
KOTA Territory News:  similar ...
New Survey Reinforces Link between Asthma and Allergic Rhinitis: 67% of respondents diagnosed with asthma also
PharmiWeb:  similar ...
Cockroach Immunotherapy Effective in Patients With Allergic Rhinitis, Asthma: Presented at EAACI
Doctors Guide:  similar ...
Cockroach Immunotherapy Effective in Patients With Allergic Rhinitis, Asthma: Presented at EAACI
PSL Group:  similar ...
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Al
Financials.com:  similar ...
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Al
KOTA Territory News:  similar ...
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of M
Interest!ALERT:  similar ...
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Al
Pharma Live:  similar ...
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Al
Earthtimes.org:  similar ...
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Al
KRON4:  similar ...
Healthline Launches HealthSTAT On-demand, the First Ad Serving Platform to Deliver Contextually Relevant Healt
Pharma Live:  similar ...
Desloratadine/Pseudoephedrine Combination More Effective Than Individual Components for Treatment of Seasonal
Doctors Guide:  similar ...
'Dry Eye' syndrome wreaks havoc on Brits
Easier:  similar ...
TopAbstracts in Rhinitis 06/02/2008
Doctors Guide:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.